Open AccessThis article is
- freely available
Advances in Bio-Optical Imaging for the Diagnosis of Early Oral Cancer
School of Physics, National University of Ireland Galway, Ireland
Department of Pharmacy, National University of Singapore, No. 18 Science Drive 4, Block S4, 117543, Singapore
National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore
Consultant Otolaryngologist, Head & Neck Surgeon, Academic Department of Otorhinolaryngology, National University of Ireland Galway & Galway University Hospitals, Ireland
These authors contributed equally to this work.
* Author to whom correspondence should be addressed.
Received: 4 May 2011; Accepted: 27 June 2011 / Published: 11 July 2011
Abstract: Oral cancer is among the most common malignancies worldwide, therefore early detection and treatment is imperative. The 5-year survival rate has remained at a dismal 50% for the past several decades. The main reason for the poor survival rate is the fact that most of the oral cancers, despite the general accessibility of the oral cavity, are not diagnosed until the advanced stage. Early detection of the oral tumors and its precursor lesions may be the most effective means to improve clinical outcome and cure most patients. One of the emerging technologies is the use of non-invasive in vivo tissue imaging to capture the molecular changes at high-resolution to improve the detection capability of early stage disease. This review will discuss the use of optical probes and highlight the role of optical imaging such as autofluorescence, fluorescence diagnosis (FD), laser confocal endomicroscopy (LCE), surface enhanced Raman spectroscopy (SERS), optical coherence tomography (OCT) and confocal reflectance microscopy (CRM) in early oral cancer detection. FD is a promising method to differentiate cancerous lesions from benign, thus helping in the determination of adequate resolution of surgical resection margin. LCE offers in vivo cellular imaging of tissue structures from surface to subsurface layers and has demonstrated the potential to be used as a minimally invasive optical biopsy technique for early diagnosis of oral cancer lesions. SERS was able to differentiate between normal and oral cancer patients based on the spectra acquired from saliva of patients. OCT has been used to visualize the detailed histological features of the oral lesions with an imaging depth down to 2–3 mm. CRM is an optical tool to noninvasively image tissue with near histological resolution. These comprehensive diagnostic modalities can also be used to define surgical margin and to provide a direct assessment of the therapeutic effectiveness.
Keywords: oral cancer; optical imaging; fluorescence diagnosis; confocal endomicroscopy; surface enhanced Raman spectroscopy; optical coherence tomography; confocal reflectance microscopy
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Olivo, M.; Bhuvaneswari, R.; Keogh, I. Advances in Bio-Optical Imaging for the Diagnosis of Early Oral Cancer. Pharmaceutics 2011, 3, 354-378.
Olivo M, Bhuvaneswari R, Keogh I. Advances in Bio-Optical Imaging for the Diagnosis of Early Oral Cancer. Pharmaceutics. 2011; 3(3):354-378.
Olivo, Malini; Bhuvaneswari, Ramaswamy; Keogh, Ivan. 2011. "Advances in Bio-Optical Imaging for the Diagnosis of Early Oral Cancer." Pharmaceutics 3, no. 3: 354-378.